ATTUNE NEUROSCIENCES INC

Attune Neurosciences is developing a wearable, non-invasive ultrasound platform for precision neuromodulation of the deep brain, aimed at treating brain disorders and improving cognitive performance. The company positions focused ultrasound as an alternative to medications, which lack precision and cause side effects, and to electrical stimulation, which requires surgery and carries risks, citing ultrasound's non-invasive, millimeter-level accuracy. Attune describes its device as the first wearable platform designed to deliver targeted, adaptive ultrasound therapy to the deep brain, intended to make the technology practical, personalized, and accessible for everyday use. The device is currently an investigational device limited under United States law to investigational use. Collaborators and investors named on the company's site include DARPA, the National Institutes of Health, UCSF, USSOCOM, Genoa Ventures, Satori Capital, and One Mind.